Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00006481 · ClinicalTrials.gov registry record · Phase 3
Biafine Cream to Reduce Side Effects of Radiation Therapy in Patients Receiving Treatment for Advanced Head and Neck Cancer
A Phase 3 study of Head and Neck Cancer and Skin Reactions Secondary to Radiation Therapy, sponsored by Radiation Therapy Oncology Group.
- Completed
- Registry status
- Phase 3
- Development phase
- 20
- Study locations
NCT00006481: Completed Phase 3 study of Head and Neck Cancer and Skin Reactions Secondary to Radiation Therapy, sponsored by Radiation Therapy Oncology Group.
NCT00006481 is a Phase 3 study of Head and Neck Cancer and Skin Reactions Secondary to Radiation Therapy that has completed, run by Radiation Therapy Oncology Group. The trial reports 20 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00006481, a Phase 3 study of Head and Neck Cancer and Skin Reactions Secondary to Radiation Therapy, has completed, sponsored by Radiation Therapy Oncology Group.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 20
- Study locations
Study Summary
RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells, but may cause skin irritation and inflammation. Biafine cream may be effective in lessening side effects caused by radiation therapy. PURPOSE: Randomized phase III trial to determine the effectiveness of Biafine cream in reducing side effects of radiation therapy in patients receiving treatment for head and neck cancer.
Conditions Studied
Interventions
- PROCEDURE quality-of-life assessment
- RADIATION radiation therapy
- DRUG Biafine cream
Study Locations (20)
California
- Mount Diablo Medical Center - Concord
- Cancer Center and Beckman Research Institute, City of Hope - Duarte
- California Cancer Center - Fresno
- Saint Agnes Cancer Center - Fresno
- Glendale Memorial Hospital and Health Center - Glendale
- Sutter Health West Cancer Research Group - Greenbrae
- University of California San Diego Cancer Center - La Jolla
- Loma Linda University Medical Center - Loma Linda
- Veterans Affairs Medical Center - Long Beach - Long Beach
- USC/Norris Comprehensive Cancer Center and Hospital - Los Angeles
Alabama
- University of Alabama at Birmingham Comprehensive Cancer Center - Birmingham
- Huntsville Hospital System - Huntsville
- Comprehensive Cancer Institute of Huntsville - Huntsville
- MBCCOP - Gulf Coast - Mobile
- Alabama Oncology, LLC - Montgomery
- Radiation Oncology Associates of West Alabama - Tuscaloosa
Arizona
- Foundation for Cancer Research and Education - Phoenix
- Arizona Cancer Center - Tucson
Alaska
- Providence Alaska Medical Center - Anchorage
Arkansas
- University of Arkansas for Medical Sciences - Little Rock
Trial Details
| Field | Value |
|---|---|
| Start Date | 2000-10 |
| Phase | Phase 3 |
What the finished NCT00006481 record still lists
NCT00006481 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 2 conditions, with Head and Neck Cancer appearing as the primary indexed condition, and to 3 interventions - of which quality-of-life assessment is the first listed.
NCT00006481 names 20 study sites across 5 states, led by California, Alabama, Arizona.
Frequently Asked Questions
What is clinical trial NCT00006481 about?
NCT00006481 is a clinical study titled "Biafine Cream to Reduce Side Effects of Radiation Therapy in Patients Receiving Treatment for Advanced Head and Neck Cancer". RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells, but may cause skin irritation and inflammation. Biafine cream may be effective in lessening side effects caused by radiation therapy. PURPOSE: Randomized phase III trial to determine the effectiveness of Biafine cream in re...
What is the current status of trial NCT00006481?
This trial is currently completed. It is a Phase 3 study. The study started on 2000-10.
What conditions does trial NCT00006481 study?
This clinical trial studies the following conditions: Head and Neck Cancer, Skin Reactions Secondary to Radiation Therapy.
What interventions are being tested in trial NCT00006481?
The interventions under investigation include: quality-of-life assessment (PROCEDURE), radiation therapy (RADIATION), Biafine cream (DRUG).
Who is sponsoring clinical trial NCT00006481?
This trial is sponsored by Radiation Therapy Oncology Group, which has 144 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00006481 being conducted?
This trial has 20 study locations across Alabama, Alaska, Arizona, Arkansas, California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Head and Neck Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Addressing Taste Dysfunction With Miraculin in Head and Neck Cancer Patients Receiving Radiation Therapy
RECRUITING · Phase 3
-
ASP-1929 Photoimmunotherapy (PIT) Study in Recurrent Head/Neck Cancer for Patients Who Have Failed at Least Two Lines of Therapy
ACTIVE NOT RECRUITING · Phase 3
-
Tumescence in HNC Skin Graft Reconstruction
ACTIVE NOT RECRUITING · Phase 3
-
RT With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer
ACTIVE NOT RECRUITING · Phase 3
-
Controlled Trial Of Acupuncture To Prevent Radiation-Induced Xerostomia
ACTIVE NOT RECRUITING · Phase 3
-
Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia